836 related articles for article (PubMed ID: 31928221)
1. Myocardin and myocardin-related transcription factor-A synergistically mediate actin cytoskeletal-dependent inhibition of liver fibrogenesis.
Shi Z; Ren M; Rockey DC
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G504-G517. PubMed ID: 31928221
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of the actin cytoskeleton via myocardin leads to increased expression of type 1 collagen.
Shi Z; Rockey DC
Lab Invest; 2017 Dec; 97(12):1412-1426. PubMed ID: 29035375
[TBL] [Abstract][Full Text] [Related]
3. Myocardin related transcription factor A programs epigenetic activation of hepatic stellate cells.
Tian W; Hao C; Fan Z; Weng X; Qin H; Wu X; Fang M; Chen Q; Shen A; Xu Y
J Hepatol; 2015 Jan; 62(1):165-74. PubMed ID: 25109772
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling and functional assays of activated hepatic stellate cells suggest that myocardin has a role in activation.
Shimada H; Ochi T; Imasato A; Morizane Y; Hori M; Ozaki H; Shinjo K
Liver Int; 2010 Jan; 30(1):42-54. PubMed ID: 19793196
[TBL] [Abstract][Full Text] [Related]
5. Aryl Hydrocarbon Receptor Signaling Prevents Activation of Hepatic Stellate Cells and Liver Fibrogenesis in Mice.
Yan J; Tung HC; Li S; Niu Y; Garbacz WG; Lu P; Bi Y; Li Y; He J; Xu M; Ren S; Monga SP; Schwabe RF; Yang D; Xie W
Gastroenterology; 2019 Sep; 157(3):793-806.e14. PubMed ID: 31170413
[TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone Inhibits Activation of Hepatic Stellate Cells via Up-Regulating Micro-RNA-124-3p to Alleviate Hepatic Fibrosis.
Zhi SC; Chen SZ; Li YY; Li JJ; Zheng YH; Yu FX
Dig Dis Sci; 2019 Jun; 64(6):1560-1570. PubMed ID: 30673982
[TBL] [Abstract][Full Text] [Related]
7. Moesin, an Ezrin/Radixin/Moesin Family Member, Regulates Hepatic Fibrosis.
Karvar S; Ansa-Addo EA; Suda J; Singh S; Zhu L; Li Z; Rockey DC
Hepatology; 2020 Sep; 72(3):1073-1084. PubMed ID: 31860744
[TBL] [Abstract][Full Text] [Related]
8. Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/mTOR/p70S6K and TGFβ/Smad signalling pathways.
Li J; Li X; Xu W; Wang S; Hu Z; Zhang Q; Deng X; Wang J; Zhang J; Guo C
Liver Int; 2015 Apr; 35(4):1222-33. PubMed ID: 25040634
[TBL] [Abstract][Full Text] [Related]
9. Role of growth factor receptor-bound 2 in CCl
Ge S; Xiong Y; Wu X; Xie J; Liu F; He J; Xiang T; Cheng N; Lai L; Zhong Y
Biomed Pharmacother; 2017 Aug; 92():942-951. PubMed ID: 28618656
[TBL] [Abstract][Full Text] [Related]
10. New role and molecular mechanism of Gadd45a in hepatic fibrosis.
Hong L; Sun QF; Xu TY; Wu YH; Zhang H; Fu RQ; Cai FJ; Zhou QQ; Zhou K; Du QW; Zhang D; Xu S; Ding JG
World J Gastroenterol; 2016 Mar; 22(9):2779-88. PubMed ID: 26973416
[TBL] [Abstract][Full Text] [Related]
11. Ablation of serum response factor in hepatic stellate cells attenuates liver fibrosis.
Kong M; Hong W; Shao Y; Lv F; Fan Z; Li P; Xu Y; Guo J
J Mol Med (Berl); 2019 Nov; 97(11):1521-1533. PubMed ID: 31435710
[TBL] [Abstract][Full Text] [Related]
12. A lncRNA Gpr137b-ps/miR-200a-3p/CXCL14 axis modulates hepatic stellate cell (HSC) activation.
Liao J; Zhang Z; Yuan Q; Liu Q; Kuang J; Fang Y; Hu X
Toxicol Lett; 2021 Jan; 336():21-31. PubMed ID: 33069761
[TBL] [Abstract][Full Text] [Related]
13. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway.
Mu M; Zuo S; Wu RM; Deng KS; Lu S; Zhu JJ; Zou GL; Yang J; Cheng ML; Zhao XK
Drug Des Devel Ther; 2018; 12():4107-4115. PubMed ID: 30584275
[TBL] [Abstract][Full Text] [Related]
14. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
[TBL] [Abstract][Full Text] [Related]
15. Amygdalin inhibits TGFβ1-induced activation of hepatic stellate cells (HSCs) in vitro and CCl
Wang R; Zhang D; Tang D; Sun K; Peng J; Zhu W; Yin S; Wu Y
Int Immunopharmacol; 2021 Jan; 90():107151. PubMed ID: 33296784
[TBL] [Abstract][Full Text] [Related]
16. Plumbagin protects liver against fulminant hepatic failure and chronic liver fibrosis via inhibiting inflammation and collagen production.
Wang H; Zhang H; Zhang Y; Wang D; Cheng X; Yang F; Zhang Q; Xue Z; Li Y; Zhang L; Yang L; Miao G; Li D; Guan Z; Da Y; Yao Z; Gao F; Qiao L; Kong L; Zhang R
Oncotarget; 2016 Dec; 7(50):82864-82875. PubMed ID: 27756878
[TBL] [Abstract][Full Text] [Related]
17. 3,3'-Diindolylmethane ameliorates experimental hepatic fibrosis via inhibiting miR-21 expression.
Zhang Z; Gao Z; Hu W; Yin S; Wang C; Zang Y; Chen J; Zhang J; Dong L
Br J Pharmacol; 2013 Oct; 170(3):649-60. PubMed ID: 23902531
[TBL] [Abstract][Full Text] [Related]
18. The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis.
Hu J; Chen C; Liu Q; Liu B; Song C; Zhu S; Wu C; Liu S; Yu H; Yao D; Kang J; Zhu L
Clin Sci (Lond); 2015 Aug; 129(4):305-17. PubMed ID: 25728779
[TBL] [Abstract][Full Text] [Related]
19. Fibromodulin, an oxidative stress-sensitive proteoglycan, regulates the fibrogenic response to liver injury in mice.
Mormone E; Lu Y; Ge X; Fiel MI; Nieto N
Gastroenterology; 2012 Mar; 142(3):612-621.e5. PubMed ID: 22138190
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of matrilin-2 expression in murine hepatic stellate cells during liver injury has no effect on fibrosis formation and resolution.
Hintermann E; Bayer M; Pfeilschifter JM; Deák F; Kiss I; Paulsson M; Christen U
Liver Int; 2015 Apr; 35(4):1265-73. PubMed ID: 24905825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
